2016年3月17日至18日，由国家新药筛选中心和新西兰皇后镇分子生物学会议机构主办、复旦大学药学院和上海市浦东新区工程师协会协办的主题为“药物发现与转化医学”的2016年皇后镇分子生物学（上海）会议在浦东陆家嘴中国金融信息中心举行。第八届全国药物筛选新技术研讨会和中国热带病药物与诊断创新网络第五次会议也同期召开。
本次活动得到了国家卫计委“重大新药创制”科技重大专项课题管理办公室、国家科技部、中国科学院、复旦大学、中国科学院上海药物研究所、中国金融信息中心（新华社）、上海市旅游局、新西兰莫里斯·威尔金斯中心、丹麦诺和诺德公司、中国疾病预防控制中心寄生虫病研究所、国家化合物样品库、世界卫生组织热带病研究和培训特别规划署、浦东新区科协、张江高科技园区管委会、《中国药理学报》、亚洲化学生物学行动计划、中国热带病药物与诊断创新网络和上海市研发公共服务平台等的支持。国家新药筛选中心主任、复旦大学药学院院长王明伟研究员和新西兰奥克兰大学Peter Shepherd教授共同主持了两天的会议。
会议吸引了近500名海内外科学家、企业家、投资者、经理人和研究生的参加，他们围绕“药物发现与转化医学”这个主题进行了广泛的交流和热烈的互动。102位来自全球16个国家和地区（其中境外人士占53%）的嘉宾应邀分10个论坛作了精彩的演讲，其中不仅有多名国际学界巨擘，还有10位来自中日两国的青年研究者。18家从事科学仪器、实验试剂和耗材研发销售的海内外公司为本次会议提供了赞助，其中8家公司委派代表在会上介绍了国际新药创制的新趋势、新策略、新技术、新方法、新手段和新设备等热点议题。10名获奖青年艺术家以其精湛的表演为与会人员带来了两场令人难忘的音乐会。
皇后镇分子生物学会议是国际著名品牌学术论坛，25年多来吸引了无数科学家、学生和创业人士的参加，这是继2013年首次在上海举办后的第四次盛会。
2016 Queenstown Molecular Biology (Shanghai) Meetings held in Pudong Lujiazui
The 2016 Queenstown Molecular Biology (Shanghai) Meetings, organized by the National Center for Drug Screening and the Queenstown Molecular Biology Meeting Society of New Zealand were held at China Financial Information Center located in Lujiazui, Pudong between March 17 and 18, 2016. School of Pharmacy, Fudan University and Shanghai Pudong Engineers Association assisted in the organization. The main theme of this event is “Drug Discovery and Translational Medicine”, which was concurrent with the 8th National Forum on New Technologies in Drug Discovery and the 5th Meeting of Chinese Network for Drugs and Diagnostics Innovation.
Among the sponsors were the National Health and Family Planning Commission, Ministry of Sciences and Technology, Chinese Academy of Sciences (CAS), Fudan University, Shanghai Institute of Materia Medica, CAS, China Financial Information Center (affiliated to Xinhua News Agency), Shanghai Municipal Tourism Administration, Maurice Wilkins Center of New Zealand, Novo Nordisk A/S of Denmark, the National Institute of Parasitic Diseases (IPD), Chinese Center for Disease Control and Prevention (China CDC), the Chinese National Compound Library, the Special Programme for Research and Training in Tropical Diseases (TDR/WHO), Shanghai Pudong Association for Science and Technology, Zhangjiang High-Tech Park, Acta Pharmacologica Sinica, Asian Chemical Biology Initiative, Chinese Network for Drugs and Diagnostics Innovation and Shanghai Research and Development Public Service Platform. Drs. Ming-Wei Wang (Director of the National Center for Drug Screening and Dean of Fudan School of Pharmacy) and Peter Shepherd (Professor of the University of Auckland, New Zealand) co-chaired the 2-day meetings.
Approximately 500 domestic and overseas scientists, entrepreneurs, investors, managers and graduate students attended the meetings. They conducted broad exchanges and interacted enthusiastically surrounding the theme of “Drug Discovery and Translational Medicine”. One hundred and two invited speakers from 16 countries and regions (53% of them were from overseas), including several internationally renowned scholars and 10 young investigators from Japan and China, made their presentations in 10 parallel sessions. Eighteen multinational or domestic instrument/reagent/consumable vendors provided financial support to the event; 8 of them sent their representatives to give oral introductions to the audience covering various hot topics in global drug innovation, ranging from new trends, new strategies, new technologies, to new methods, new tools and new instruments. Ten award-winning young artists brought about their exquisite performances by presenting two memorable concerts during the meetings.
Queenstown Molecular Biology Meetings are a well-known international academic forum with a history of more than 25 years, which have attracted the attendance of numerous scientists, students and entrepreneurs. This is the fourth time to hold such a prestigious event outside of New Zealand, following a successful launching in Shanghai in 2013.
